NOL in Australia:
We are happy to share with you that Medasense received approval to market the PMD-200™ system in Australia, strengthening commercial presence around the world.
The PMD-200™ and its NOL® index are currently commercially available in Europe, Canada, Australia and Israel.
Please note that it is not commercially available yet in the USA.